Escope Tech Co., Ltd. is a technology-driven company focusing on the diagnostic techniques for panvascular diseases including heart diseases and brain diseases. In 2017, the company was founded by the talents in the realm of clinical medicine, computer science and mechanical engineering. In the new era of medical diagnosis, data-driven technologies like deep learning and machine learning along with knowledge-driven technologies, such as computational medicine, computational aided engineering, digital twins, etc emerged as the cornerstones of computational medicine. Escope Tech is committed to creating a world-leading medical imaging and data analysis platform for cardiovascular and cerebrovascular diseases. With the help of artificial intelligence, imaging, machine vision, simulation science, data mining and other underlying technologies, the company has achieved fully upgrade of clinics from imaging morphological indicators to imaging functional indicators. At present, our product lines cover the clinical assessments of the following five main fields, which are coronary artery, cardiac/heart function, intracranial artery, cerebral/brain function and peripheral artery.
Xiang Qian, MD, PhD, is a Pain Management Physician and Clinical Associate Professor of Anesthesiology, Perioperative and Pain Medicine at Stanford University. He is also the inaugural Stanford Medicine Endowed Director.<br/> At Stanford, Dr. Qian developed many advanced surgical and interventional technologies for his patients, and he currently leads the CT-guided interventional pain program and is the recipient of Translational and Clinical Innovation Award at Stanford.
Professor of Cardiovascular Medicine in University Medical Line, Medicine, Member of Cardiovascular Institute, Medical Director of Cardiovascular Health in Stanford Medicine, Senior Medical Director of International Medical Service in Stanford Medicine.
Xiang Qian, MD, PhD, is a Pain Management Physician and Clinical Associate Professor of Anesthesiology, Perioperative and Pain Medicine at Stanford University. He is also the inaugural Stanford Medicine Endowed Director.<br/> At Stanford, Dr. Qian developed many advanced surgical and interventional technologies for his patients, and he currently leads the CT-guided interventional pain program and is the recipient of Translational and Clinical Innovation Award at Stanford.
We believe that AI technology based on big data can be used to obtain imaging diagnosis through deep learning more quickly and accurately, and we believe that AI will play an increasingly prominent role in cardiovascular imaging in the future. In addition, in view of the limitations of a single imaging technology, multiple imaging technologies are organically combined to give more play to their own technical advantages, and complement their own shortcomings, namely, the multimodality of cardiovascular imaging technology, which will provide more comprehensive and systematic information support for the diagnosis and treatment of vascular diseases. In short, intelligence, precision and multimodality will be an important direction for the future development of cardiovascular imaging technology. Escope Tech hopes to be a trustworthy imaging think tank for doctors and help the development of precision medicine in China!
